Insamhodo-tang, a traditional Korean medicine, regulates mast cell-mediated allergic inflammation in vivo and in vitro

Journal of Ethnopharmacology

Volumn 134, Issue 2, 2011, Pages 339-347

  Kim, Su Jin ^a   Kee, Ji Ye ^b   Choi, In Young ^a   Kim, Min Cheol ^b   Kim, Dae Seung ^b   Jeon, Yong Deok ^b   Kim, Se Gun ^b   Kim, Beom Su ^b   Jung, Hyun Ju ^b   Kim, Hyung Min ^a   Hong, Seung Heon ^b   Um, Jae Young ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang Oriental Medicines Research Institute   (South Korea)

Author keywords

Allergic inflammation; Caspase 1; Insamhodo tang; Interlukin 6; Mast cells; Nuclear factor B

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ANTIINFLAMMATORY AGENT; COMPOUND 48-80; HERBACEOUS AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSAMHODO TANG; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANAPHYLACTIC SHOCK; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MAST CELL; MOUSE; NONHUMAN; OTITIS;

ANAPHYLAXIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCIMYCIN; DERMATITIS; DINITROFLUOROBENZENE; EDEMA; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INFLAMMATION MEDIATORS; IONOPHORES; MALE; MAST CELLS; MEDICINE, KOREAN TRADITIONAL; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; P-METHOXY-N-METHYLPHENETHYLAMINE; PHYTOTHERAPY; PLANT EXTRACTS;

MUS;

EID: 79952693881     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.12.023     Document Type: Article

References (44)

1. Allam, J.P., Novak, N., 2006. The pathophysiology of atopic eczema. Clinical and Experimental Dermatology 31, 89-93.
2. Arend, W.P., Dayer, J.M., 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheumatism 38, 151-160.
3. Baldwin Jr., A.S., 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology 14, 649-683.
4. Borsch-Haubold, A.G., Pasquet, S., Watson, S.P., 1998. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. The Journal of Biological Chemistry 273, 28766-28772. (Pubitemid 28507565)
5. Boudreau, R.T., Hoskin, D.W., Lin, T.J., 2004. Phosphatase inhibition potentiates IL-6 production by mast cells in response to FcepsilonRI-mediated activation: involvement of p38 MAPK. Journal of Leukocyte Biology 76, 1075-1081. (Pubitemid 39458719)
6. Bradding, P., Feather, I.H., Wilson, S., Bardin, P.G., Heusser, C.H., Holgate, S.T., Howarth, P.H., 1993. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5 and IL-6 in human allergic mucosal inflammation. Journal of Immunology 151, 3853-3865. (Pubitemid 23282697)
7. Brenninkmeijer, E.E., Spuls, P.I., Legierse, C.M., Lindeboom, R., Smitt, J.H., Bos, J.D., 2008. Clinical differences between atopic and atopiform dermatitis. Journal of the American Academy of Dermatology 58, 407-414. (Pubitemid 351226310)
8. Bunikowski, R., Gerhold, K., Bräutigam, M., Hamelmann, E., Renz, H., Wahn, U., 2001. Effect of low-dose cyclosporin Amicroemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. International Archives of Allergy and Immunology 125, 344-348. (Pubitemid 34704647)
9. Buske-Kirschbaum, A., Geiben, A., Hellhammer, D., 2001. Psychobiological aspects of atopic dermatitis: an overview. Psychotherapy and Psychosomatics 70, 6-16. (Pubitemid 32041457)
10. Chin, A.I., Dempsey, P.W., Bruhn, K., Miller, J.F., Xu, Y., Cheng, G., 2002. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416, 190-194. (Pubitemid 34246478)
11. Cooper, K.D., 1994. Atopic dermatitis: recent trends in pathogenesis and therapy. Journal of Investigative Dermatology 102, 128-137. (Pubitemid 24039577)
12. Feoktistov, I., Goldstein, A.E., Biaggioni, I., 1999. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Molecular Pharmacology 55, 726-734. (Pubitemid 29165438)
13. Finco, T., Baldwin Jr., A.S., 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3, 263-272.
14. Galli, S.J., Gordon, J.R., Wershil, B.K., 1991. Cytokine production by mast cells and basophils. Currrent Opinion in Immunology 3, 865-872.
15. Galli, S.J., Kalesnikoff, J., Grimbaldeston, M.A., Piliponsky, A.M., Williams, C.M., Tsai, M., 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annual Review of Immunology 23, 749-786.
16. Ghosh, S., May, M.J., Kopp, E.B., 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of immunology 16, 225-260. (Pubitemid 28183365)
17. Gold, M.S., Kemp, A.S., 2005. Atopic disease in childhood. Medical Journal of Australia 182, 298-304.
18. Gordon, J.R., Galli, S.J., 1990. Mast cells as a source of both preformed and immunologically inducible TNF-/cachectin. Nature 346, 274-276.
19. Guo, X., Gerl, R.E., Schrader, J.W., 2003. Defining the involvement of p38alpha MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase. The Journal of Biological Chemistry 278, 22237-22242. (Pubitemid 36830270)
20. Hong, S.H., Kim, M.S., Lee, J.Y., Hwang, C.Y., Baek, S.H., Han, D.S., Jung, W.Y., Seo, S.B., Kajiuchi, T., Kim, H.M., 2001. Novel finding in inhibition of mast cell dependent immediate type coetaneous reactions by Gahmi-Shini-San. Clinica Chimica Acta 309, 85-90. (Pubitemid 32530741)
21. Humke, E.W., Shriver, S.K., Starovasnik, M.A., Fairbrother, W.J., Dixit, V.M., 2000. ICEBERG: a novel inhibitor of interleukin-1β generation. Cell 103, 99-111.
22. Jeong, H.J., Chung, H.S., Lee, B.R., Kim, S.J., Yoo, S.J., Hong, S.H., Kim, H.M., 2003. Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochemical and Biophysical Research Communications 306, 805-811.
23. Kobayashi, K., Inohara, N., Hernandez, L.D., Galán, J.E., Núñez, G., Janeway, C.A., Medzhitov, R., Flavell, R.A., 2002. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416, 194-199. (Pubitemid 34246479)
24. Kong, D.K., Park, H., Li, R.H., Jeon, H., Kwon, J., Ahn, M.S., Eun, J.S., 2007. Comparative study of Ginseng radix and Insamhodo-tang on immune reaction. Korean Journal of Oriental Pathology and Pathology 21, 1219-1225.
25. Lee, S.H., Stehlik, C., Reed, J.C., 2001. Cop, a caspase recruitment domaincontaining protein and inhibitor of caspase-1 activation processing. The Journal of Biological Chemistry 276, 34495-34500.
26. Leung, D.Y., Bieber, T., 2003. Atopic dermatitis. Lancet 361, 151-160. (Pubitemid 36092023)
27. Liu, Z.C., 1983. Zongyimianyi. Chongqing publisher, Chongqing, pp. 15-20.
28. McCarthy, J.V., Ni, J., Dixit, V.M., 1998. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. Journal of Biological Chemistry 273, 16968-16975. (Pubitemid 28311729)
29. Marín, A., Eseverri, J.L., Botey, J., 1998. From atopic dermatitis to asthma. Allergologia et Immunopathologia 26, 114-119.
30. Mukaida, N., 2000. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. International Journal of Hematology 72, 391-398.
31. Nagai, H., Hiyama, H., Matsuo, A., Ueda, Y., Inagaki, N., Kawada, K., 1997. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. Journal of Pharmacology and Experimental Therapeutics 283, 321-327. (Pubitemid 27438977)
32. Navas, T.A., Baldwin, D.T., Stewart, T.A., 1999. RIP2 is a Raf1-activated mitogen activated protein kinase kinase. Journal of Biological Chemistry 274, 33684-33690. (Pubitemid 129511682)
33. Ono, K., Han, J., 2000. The p38 signal transduction pathway: activation and function. Cellular Signaling 12, 1-13. (Pubitemid 30017963)
34. Schoonbroodt, S., Legrand-Poels, S., Best-Belpomme, M., Piette, J., 1997. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. The Biochemical Journal 321, 777-785. (Pubitemid 27084888)
35. Sengupta, B., Banerjee, A., Sengupta, P.K., 2004. Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranes. FEBS Letters 570, 77-81. (Pubitemid 38900960)
36. Shiohara, T., Hayakawa, J., Mizukawa, Y., 2004. Animal models for atopic dermatitis: are they relevant to human disease? Journal of Dermatological Science 36, 1-9.
37. Shin, B.K., Lee, E.H., Kim, H.M., 1997. Suppression of l-histidine decarboxylase mRNA expression by methyleugenol. Biochemical and Biophysical Research Communications 232, 188-191.
38. Shore, P.A., Burkhalter, A., Cohn, V.H., 1959. A method for fluorometric assay of histamine in tissues. Journal of Pharmacology and Experimental Therapeutics 127, 182-186.
39. Sillaber, C., Bevec, D., Butterfield, J.H., Heppner, C., Valenta, R., Scheiner, O., Kraft, D., Lechner, K., Bettelheim, P., Valent, P., 1993. Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Experimental Hematology 21, 1271-1275. (Pubitemid 24267140)
40. Tasaka, K., Mio, M., Okamoto, M., 1986. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Annals of Allergy Asthma & Immunology 56, 464-469. (Pubitemid 16086798)
41. Tegeder, I., Pfeilschifter, J., Geisslinger, G., 2001. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. The FASEB journal: Official Publication of the Federation of American Societies for Experimental Biology 15, 2057-2072. (Pubitemid 32927924)
42. Thanos, D., Maniatis, T., 1995. NF-κB: a lesson in family values. Cell 80, 529-532.
43. Trefzer, U., Hofmann, M., Sterry, W., Asadullah, K., 2003. Cytokine and anticytokine therapy in dermatology. Expert Opinion on Biological Therapy 3, 733-743. (Pubitemid 36934973)
44. Wang, X., Wang, H.Y., Bryan, E.F., Zhang, W.H., Huo, C.F., Guan, Y.J., Zhang, Y., Bruey, J.M., John, C.R., Robert, M.F., 2005. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25, 11645-11654. (Pubitemid 43098457)